Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease
- 30 April 1999
- journal article
- research article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 117 (4), 719-727
- https://doi.org/10.1016/s0022-5223(99)70292-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Localized form of bronchioloalveolar carcinoma: FDG PET findings.American Journal of Roentgenology, 1998
- Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.Radiology, 1997
- Positron emission tomography in the clinical evaluation of metastatic cancer.Journal of Clinical Oncology, 1996
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucoseThe Annals of Thoracic Surgery, 1994
- Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.Radiology, 1992
- CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.Radiology, 1991
- Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.Radiology, 1988
- Glucose utilizationin vivo by human pulmonary neoplasmsCancer, 1987
- Roentgenographic Evaluation of Mediastinal Nodes for Preoperative Assessment in Lung CancerChest, 1985